IL6 and cardiac hypertrophy: They also further our understanding of the key role that cardiac fibroblasts have in regulating cardiac hypertrophy and remodeling through paracrine signaling, and our findings identify the cardiac fibroblast p38α/IL-6 axis as a potential therapeutic target in this setting.